Daily non-political popular news in brief.

Optimal systemic and splanchnic hemodynamic state after living-donor liver transplantation

Prior to undergoing living-donor liver transplantation, cirrhotic recipients generally develop peculiar systemic and splanchnic hemodynamics due to portal hypertension. Previously, a research group in Kyoto, Japan, reported that systemic hemodynamics affecting post-operative graft function are crucial for LDLT. This group has found the relationship between systemic hemodynamics and splanchnic circulation after LDLT and has discussed the optimal hemodynamic state for successful outcomes after LDLT.

Read more »

Keywords: optimal, systemic, splanchnic, hemodynamic, state, living-donor, liver, transplantation, living, donor

« Previous | Next »

Similar news on "Optimal systemic and splanchnic hemodynamic state after living-donor liver transplantation":

1. Predicting survival after liver transplant
   11-02-2006 · EurekAlert!
   A new model based on specific characteristics of the donor and the recipient may help predict survival after liver transplantation, according to a new study.
   Similar news · Read more »
   
2. CT and MRI accurate for pre-transplant evaluation of patients with cirrhosis
   05-04-2007 · EurekAlert!
   CT and MRI are highly accurate at determining which patients would be optimal candidates for liver transplantation, says a recent study.
   Similar news · Read more »
   
3. Working up potential living liver donors
   04-03-2007 · EurekAlert!
   Voluntary living liver donors should undergo a careful, but quick, workup and their desire for altruism should not be hampered by negativism from the transplant community, say the authors of a new study in the April issue of Liver Transplantation, the official journal of the American Association for the Study of Liver Diseases (AASLD) and the International Liver Transplantation Society (ILTS).
   Similar news · Read more »
   
4. Postoperative complications of living right liver donors
   06-04-2007 · EurekAlert!
   More than 78 percent of living right liver donors experienced post-operative complications, according to a new study that uses a replicable complication classification system. Most of the complications were minor, though some were more serious. The full findings are published in Liver Transplantation, a journal by John Wiley & Sons.
   Similar news · Read more »
   
5. Better life support for artificial liver cells
   08-23-2007 · EurekAlert!
   Researchers at Ohio State University are developing technology for keeping liver cells alive and functioning normally inside bioartificial liver-assist devices. Such devices enable people who are suffering from acute liver failure to survive while their own liver cells regenerate, or until they receive a liver transplant. The person's blood or plasma circulates through the device. Inside, living cells -- usually pig or human liver cells -- perform normal liver functions.
   Similar news · Read more »
   
6. Outcomes for patients with hepatitis B who need liver transplants
   03-02-2007 · EurekAlert!
   Survival rates are similar among patients with hepatitis B who are listed for liver transplantation, whether or not they have hepatocellular carcinoma (HCC), according to a new study in the March 2007 issue of Liver Transplantation. An accompanying editorial suggests that these results affirm the current policy on the allocation of donor livers.
   Similar news · Read more »
   
7. Study evaluates why blacks do not successfully donate kidneys
   05-07-2007 · EurekAlert!
   In one of the first studies of its kind, researchers from Wake Forest University School of Medicine explored why blacks are less likely than other races to become living kidney donors, and the reasons are obesity and failure to complete the donor evaluation.
   Similar news · Read more »
   
8. Northwestern Memorial trial may wean kidney transplant patients off antirejection drugs
   01-22-2008 · EurekAlert!
   After transplant surgery, antirejection drugs for the organ recipient are a must. But prolonged use can have serious side effects, including infections, heart disease and even cancer. A team of researchers at Northwestern University's Feinberg School of Medicine is working with Northwestern Memorial Hospital's department of organ transplantation in a new study that seeks to eliminate the need for antirejection drugs by transplanting stem cells from a kidney donor's bone marrow into the organ recipient.
   Similar news · Read more »
   
9. Attenuation of NASH by stimulation of free fatty acid metabolism
   10-26-2007 · EurekAlert!
   The prevalence of obesity around the world is booming. Consequently, obesity-associated comorbid diseases, such as non-alcoholic steatohepatitis are also escalating. NASH can progress to cirrhosis and the need for liver transplantation. Thus, many researchers have sought ways to reduce the occurrence of NASH. Recent work from the Mayo Clinic has been promising. Dr. Baskin-Bey and colleagues have ameliorated steatosis, liver inflammation and injury in an animal model of NASH by the induction of key enzymes of fatty acid oxidation.
   Similar news · Read more »
   
10. LCT reports major step forward for islet transplantation in diabetes patient
    03-29-2007 · EurekAlert!
    Living Cell Technologies has published evidence outlining the survival and identification of live porcine islet cells and insulin production in a human patient with diabetes 10 years after he received a micro-encapuslated pig islet cell transplant. The paper outlines how LCT has demonstrated the long-term safety, viability and function of its encapsulated porcine islets in a human patient over an extended period of time, without the use of immunosuppression.
    Similar news · Read more »